SK3 Group Announces Healthcare of Today's Acquisition of MacuCLEAR
January 07 2010 - 4:15PM
Marketwired
SK3 Group, Inc. (PINK SHEETS: SKTO) today announces that its new
parent company, Healthcare of Today, Inc., has acquired MacuCLEAR,
Inc., a pharmaceutical company focused on discovering and
developing novel solutions for vascular disorders of the eye. SK3
has entered into a merger agreement with Healthcare of Today, Inc.
under which both companies will merger into a new Nevada
corporation, Healthcare of Today, Inc., formed for that purpose.
MC-1101, MacuCLEAR's primary product compound, is a patented,
topically delivered drug for treating and stopping the progression
of dry Age-related Macular Degeneration (AMD). MacuCLEAR
(www.macuclear.com) has an active IND for MC-1101 and has completed
a successful Phase Ib human clinical trial. The company's
groundbreaking work leverages its unique understanding of ocular
pharmacology and drug development to advance a pipeline of
proprietary pharmaceuticals. MacuCLEAR's accomplished management
team includes CTO George C. Y. Chiou, Ph. D., professor and
director of the Institute of Ocular Pharmacology and professor of
neuroscience and experimental therapeutics at Texas A&M
University System Health Science Center. Dr. Chiou previously led
the discovery of Timolol, a pioneering treatment for glaucoma.
The company's work on AMD comes at a crucial time in senior eye
care. As the population ages and baby boomers advance into their
50s and 60s, the numbers suggest there will be a virtual epidemic
of AMD. Age-related Macular Degeneration (AMD) is the most common
cause of vision loss in people 50 and older. There are two forms of
AMD: wet and dry. Currently, more than 15 million patients in the
U.S. suffer from the signs and symptoms of AMD, while an estimated
25 to 30 million patients are afflicted worldwide. However, there
is no approved drug treatment yet available to patients with dry
AMD, and only limited treatments are available for patients with
wet AMD. An astounding 90 percent of AMD patients cannot be treated
with the methods currently available.
CEO of Healthcare of Today Henry Jan says, "MacuCLEAR is devoted
to finding treatments for the millions of people who suffer from
vascular disorders of the eye. This is a huge, under-served market,
and they have the solutions. We are very proud to bring MacuCLEAR's
groundbreaking work to the Healthcare of Today family, and we look
forward to adding this new dimension to how we improve seniors'
lives every day."
Healthcare of Today (http://www.healthcareoftoday.com), based in
Burbank, California, is a vertically-integrated healthcare holding
company. Founded in 2008, it has since acquired a number of
companies, many specializing in the senior care industry. Its
subsidiaries are engaged in a wide range of businesses including:
nurse staffing, residential care facilities for the elderly, home
healthcare services, home healthcare equipment sales, healthcare
information technology, medical equipment, healthcare consulting,
insurance, data security, advanced human tissue engineering, and
more.
About SK3 Group, Inc.
SK3 Group also markets preferred medical services through its
facilitation partners to its PEO client base. Corporate information
can be found at http://www.sk3groupinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release may contain forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes", "expects", "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking statements.
This news release speaks as of the date first set forth above and
the Company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
Contacts: SK3 Group, Inc. Peter Bell President (760) 268-9611
info@sk3groupinc.com (FAX) www.sk3groupinc.com
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From May 2024 to Jun 2024
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Jun 2023 to Jun 2024